DNA Risk: HLA-Related Autoimmunity is a blood spot genetic test analyzing HLA class I, II, and MHC-related variants linked to key autoimmune conditions. It provides HLA typing and disease-associated markers for clear risk assessment, guiding targeted investigations and preventive strategies.
Findings may provide useful clinical context in individuals with autoimmune symptoms, an established diagnosis or a family history suggesting increased susceptibility. The report covers a range of conditions including coeliac disease, Graves’ disease, Hashimoto thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis and vitiligo.
Results are interpreted alongside symptom history, family history and other relevant investigations where appropriate. The test is not a diagnostic tool but may be useful for preventative measures as well as further investigation or to target broader autoimmune assessments.